Our preliminary research showed that hepatocyte growth factor (HGF) secreted by hepatic stellate cells could attenuate sorafenib‐induced cell death in HCC cells by activating the HGF/mesenchymal‐epithelial transition (MET) axis 12. The gene discussed is HGF; the disease is hepatocellular carcinoma.